Rare Disease Genetic Testing Market, Global Outlook and Forecast 2023-2029

Report ID: MMG119623 | Category: Service & Software | Pages: 104 | Format: PDF | Published Date: July 12,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

This report aims to provide a comprehensive presentation of the global market for Rare Disease Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rare Disease Genetic Testing. This report contains market size and forecasts of Rare Disease Genetic Testing in global, including the following market information:
Global Rare Disease Genetic Testing Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Rare Disease Genetic Testing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Next-Generation Sequencing (NGS) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Rare Disease Genetic Testing include Quest Diagnostics, Centogene, Invitae Corporation, 3billion, Arup Laboratories, Eurofins Scientific, Strand Life Sciences, Ambry Genetics and Perkin Elmer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rare Disease Genetic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rare Disease Genetic Testing Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Rare Disease Genetic Testing Market Segment Percentages, by Type, 2022 (%)
    Next-Generation Sequencing (NGS)
    Array Technology
    PCR-based Testing
    Fluorescence in Situ Hybridization (FISH)
    Sanger Sequencing
    Karyotyping
    Others
Global Rare Disease Genetic Testing Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Rare Disease Genetic Testing Market Segment Percentages, by Application, 2022 (%)
    Research Laboratories and CROs
    Diagnostic Laboratories
    Hospitals and Clinics
    Others
Global Rare Disease Genetic Testing Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Rare Disease Genetic Testing Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rare Disease Genetic Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Rare Disease Genetic Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Quest Diagnostics
    Centogene
    Invitae Corporation
    3billion
    Arup Laboratories
    Eurofins Scientific
    Strand Life Sciences
    Ambry Genetics
    Perkin Elmer
    Macrogen
    Baylor Genetics
    Color Genomics
    Preventiongenetics
    Progenity
    Coopersurgical
    Fulgent Genetics
    Myriad Genetics
    LabCorp
    Opko Health
Outline of Major Chapters:
Chapter 1: Introduces the definition of Rare Disease Genetic Testing, market overview.
Chapter 2: Global Rare Disease Genetic Testing market size in revenue.
Chapter 3: Detailed analysis of Rare Disease Genetic Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rare Disease Genetic Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Rare Disease Genetic Testing Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Rare Disease Genetic Testing Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Rare Disease Genetic Testing Overall Market Size
    2.1 Global Rare Disease Genetic Testing Market Size: 2022 VS 2029
    2.2 Global Rare Disease Genetic Testing Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Rare Disease Genetic Testing Players in Global Market
    3.2 Top Global Rare Disease Genetic Testing Companies Ranked by Revenue
    3.3 Global Rare Disease Genetic Testing Revenue by Companies
    3.4 Top 3 and Top 5 Rare Disease Genetic Testing Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Rare Disease Genetic Testing Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Rare Disease Genetic Testing Players in Global Market
        3.6.1 List of Global Tier 1 Rare Disease Genetic Testing Companies
        3.6.2 List of Global Tier 2 and Tier 3 Rare Disease Genetic Testing Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Rare Disease Genetic Testing Market Size Markets, 2022 & 2029
        4.1.2 Next-Generation Sequencing (NGS)
        4.1.3 Array Technology
        4.1.4 PCR-based Testing
        4.1.5 Fluorescence in Situ Hybridization (FISH)
        4.1.6 Sanger Sequencing
        4.1.7 Karyotyping
        4.1.8 Others
    4.2 By Type - Global Rare Disease Genetic Testing Revenue & Forecasts
        4.2.1 By Type - Global Rare Disease Genetic Testing Revenue, 2018-2023
        4.2.2 By Type - Global Rare Disease Genetic Testing Revenue, 2024-2029
        4.2.3 By Type - Global Rare Disease Genetic Testing Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Rare Disease Genetic Testing Market Size, 2022 & 2029
        5.1.2 Research Laboratories and CROs
        5.1.3 Diagnostic Laboratories
        5.1.4 Hospitals and Clinics
        5.1.5 Others
    5.2 By Application - Global Rare Disease Genetic Testing Revenue & Forecasts
        5.2.1 By Application - Global Rare Disease Genetic Testing Revenue, 2018-2023
        5.2.2 By Application - Global Rare Disease Genetic Testing Revenue, 2024-2029
        5.2.3 By Application - Global Rare Disease Genetic Testing Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Rare Disease Genetic Testing Market Size, 2022 & 2029
    6.2 By Region - Global Rare Disease Genetic Testing Revenue & Forecasts
        6.2.1 By Region - Global Rare Disease Genetic Testing Revenue, 2018-2023
        6.2.2 By Region - Global Rare Disease Genetic Testing Revenue, 2024-2029
        6.2.3 By Region - Global Rare Disease Genetic Testing Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Rare Disease Genetic Testing Revenue, 2018-2029
        6.3.2 US Rare Disease Genetic Testing Market Size, 2018-2029
        6.3.3 Canada Rare Disease Genetic Testing Market Size, 2018-2029
        6.3.4 Mexico Rare Disease Genetic Testing Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Rare Disease Genetic Testing Revenue, 2018-2029
        6.4.2 Germany Rare Disease Genetic Testing Market Size, 2018-2029
        6.4.3 France Rare Disease Genetic Testing Market Size, 2018-2029
        6.4.4 U.K. Rare Disease Genetic Testing Market Size, 2018-2029
        6.4.5 Italy Rare Disease Genetic Testing Market Size, 2018-2029
        6.4.6 Russia Rare Disease Genetic Testing Market Size, 2018-2029
        6.4.7 Nordic Countries Rare Disease Genetic Testing Market Size, 2018-2029
        6.4.8 Benelux Rare Disease Genetic Testing Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Rare Disease Genetic Testing Revenue, 2018-2029
        6.5.2 China Rare Disease Genetic Testing Market Size, 2018-2029
        6.5.3 Japan Rare Disease Genetic Testing Market Size, 2018-2029
        6.5.4 South Korea Rare Disease Genetic Testing Market Size, 2018-2029
        6.5.5 Southeast Asia Rare Disease Genetic Testing Market Size, 2018-2029
        6.5.6 India Rare Disease Genetic Testing Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Rare Disease Genetic Testing Revenue, 2018-2029
        6.6.2 Brazil Rare Disease Genetic Testing Market Size, 2018-2029
        6.6.3 Argentina Rare Disease Genetic Testing Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Rare Disease Genetic Testing Revenue, 2018-2029
        6.7.2 Turkey Rare Disease Genetic Testing Market Size, 2018-2029
        6.7.3 Israel Rare Disease Genetic Testing Market Size, 2018-2029
        6.7.4 Saudi Arabia Rare Disease Genetic Testing Market Size, 2018-2029
        6.7.5 UAE Rare Disease Genetic Testing Market Size, 2018-2029
7 Rare Disease Genetic Testing Companies Profiles
    7.1 Quest Diagnostics
        7.1.1 Quest Diagnostics Company Summary
        7.1.2 Quest Diagnostics Business Overview
        7.1.3 Quest Diagnostics Rare Disease Genetic Testing Major Product Offerings
        7.1.4 Quest Diagnostics Rare Disease Genetic Testing Revenue in Global Market (2018-2023)
        7.1.5 Quest Diagnostics Key News & Latest Developments
    7.2 Centogene
        7.2.1 Centogene Company Summary
        7.2.2 Centogene Business Overview
        7.2.3 Centogene Rare Disease Genetic Testing Major Product Offerings
        7.2.4 Centogene Rare Disease Genetic Testing Revenue in Global Market (2018-2023)
        7.2.5 Centogene Key News & Latest Developments
    7.3 Invitae Corporation
        7.3.1 Invitae Corporation Company Summary
        7.3.2 Invitae Corporation Business Overview
        7.3.3 Invitae Corporation Rare Disease Genetic Testing Major Product Offerings
        7.3.4 Invitae Corporation Rare Disease Genetic Testing Revenue in Global Market (2018-2023)
        7.3.5 Invitae Corporation Key News & Latest Developments
    7.4 3billion
        7.4.1 3billion Company Summary
        7.4.2 3billion Business Overview
        7.4.3 3billion Rare Disease Genetic Testing Major Product Offerings
        7.4.4 3billion Rare Disease Genetic Testing Revenue in Global Market (2018-2023)
        7.4.5 3billion Key News & Latest Developments
    7.5 Arup Laboratories
        7.5.1 Arup Laboratories Company Summary
        7.5.2 Arup Laboratories Business Overview
        7.5.3 Arup Laboratories Rare Disease Genetic Testing Major Product Offerings
        7.5.4 Arup Laboratories Rare Disease Genetic Testing Revenue in Global Market (2018-2023)
        7.5.5 Arup Laboratories Key News & Latest Developments
    7.6 Eurofins Scientific
        7.6.1 Eurofins Scientific Company Summary
        7.6.2 Eurofins Scientific Business Overview
        7.6.3 Eurofins Scientific Rare Disease Genetic Testing Major Product Offerings
        7.6.4 Eurofins Scientific Rare Disease Genetic Testing Revenue in Global Market (2018-2023)
        7.6.5 Eurofins Scientific Key News & Latest Developments
    7.7 Strand Life Sciences
        7.7.1 Strand Life Sciences Company Summary
        7.7.2 Strand Life Sciences Business Overview
        7.7.3 Strand Life Sciences Rare Disease Genetic Testing Major Product Offerings
        7.7.4 Strand Life Sciences Rare Disease Genetic Testing Revenue in Global Market (2018-2023)
        7.7.5 Strand Life Sciences Key News & Latest Developments
    7.8 Ambry Genetics
        7.8.1 Ambry Genetics Company Summary
        7.8.2 Ambry Genetics Business Overview
        7.8.3 Ambry Genetics Rare Disease Genetic Testing Major Product Offerings
        7.8.4 Ambry Genetics Rare Disease Genetic Testing Revenue in Global Market (2018-2023)
        7.8.5 Ambry Genetics Key News & Latest Developments
    7.9 Perkin Elmer
        7.9.1 Perkin Elmer Company Summary
        7.9.2 Perkin Elmer Business Overview
        7.9.3 Perkin Elmer Rare Disease Genetic Testing Major Product Offerings
        7.9.4 Perkin Elmer Rare Disease Genetic Testing Revenue in Global Market (2018-2023)
        7.9.5 Perkin Elmer Key News & Latest Developments
    7.10 Macrogen
        7.10.1 Macrogen Company Summary
        7.10.2 Macrogen Business Overview
        7.10.3 Macrogen Rare Disease Genetic Testing Major Product Offerings
        7.10.4 Macrogen Rare Disease Genetic Testing Revenue in Global Market (2018-2023)
        7.10.5 Macrogen Key News & Latest Developments
    7.11 Baylor Genetics
        7.11.1 Baylor Genetics Company Summary
        7.11.2 Baylor Genetics Business Overview
        7.11.3 Baylor Genetics Rare Disease Genetic Testing Major Product Offerings
        7.11.4 Baylor Genetics Rare Disease Genetic Testing Revenue in Global Market (2018-2023)
        7.11.5 Baylor Genetics Key News & Latest Developments
    7.12 Color Genomics
        7.12.1 Color Genomics Company Summary
        7.12.2 Color Genomics Business Overview
        7.12.3 Color Genomics Rare Disease Genetic Testing Major Product Offerings
        7.12.4 Color Genomics Rare Disease Genetic Testing Revenue in Global Market (2018-2023)
        7.12.5 Color Genomics Key News & Latest Developments
    7.13 Preventiongenetics
        7.13.1 Preventiongenetics Company Summary
        7.13.2 Preventiongenetics Business Overview
        7.13.3 Preventiongenetics Rare Disease Genetic Testing Major Product Offerings
        7.13.4 Preventiongenetics Rare Disease Genetic Testing Revenue in Global Market (2018-2023)
        7.13.5 Preventiongenetics Key News & Latest Developments
    7.14 Progenity
        7.14.1 Progenity Company Summary
        7.14.2 Progenity Business Overview
        7.14.3 Progenity Rare Disease Genetic Testing Major Product Offerings
        7.14.4 Progenity Rare Disease Genetic Testing Revenue in Global Market (2018-2023)
        7.14.5 Progenity Key News & Latest Developments
    7.15 Coopersurgical
        7.15.1 Coopersurgical Company Summary
        7.15.2 Coopersurgical Business Overview
        7.15.3 Coopersurgical Rare Disease Genetic Testing Major Product Offerings
        7.15.4 Coopersurgical Rare Disease Genetic Testing Revenue in Global Market (2018-2023)
        7.15.5 Coopersurgical Key News & Latest Developments
    7.16 Fulgent Genetics
        7.16.1 Fulgent Genetics Company Summary
        7.16.2 Fulgent Genetics Business Overview
        7.16.3 Fulgent Genetics Rare Disease Genetic Testing Major Product Offerings
        7.16.4 Fulgent Genetics Rare Disease Genetic Testing Revenue in Global Market (2018-2023)
        7.16.5 Fulgent Genetics Key News & Latest Developments
    7.17 Myriad Genetics
        7.17.1 Myriad Genetics Company Summary
        7.17.2 Myriad Genetics Business Overview
        7.17.3 Myriad Genetics Rare Disease Genetic Testing Major Product Offerings
        7.17.4 Myriad Genetics Rare Disease Genetic Testing Revenue in Global Market (2018-2023)
        7.17.5 Myriad Genetics Key News & Latest Developments
    7.18 LabCorp
        7.18.1 LabCorp Company Summary
        7.18.2 LabCorp Business Overview
        7.18.3 LabCorp Rare Disease Genetic Testing Major Product Offerings
        7.18.4 LabCorp Rare Disease Genetic Testing Revenue in Global Market (2018-2023)
        7.18.5 LabCorp Key News & Latest Developments
    7.19 Opko Health
        7.19.1 Opko Health Company Summary
        7.19.2 Opko Health Business Overview
        7.19.3 Opko Health Rare Disease Genetic Testing Major Product Offerings
        7.19.4 Opko Health Rare Disease Genetic Testing Revenue in Global Market (2018-2023)
        7.19.5 Opko Health Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Rare Disease Genetic Testing Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?